跳至主要内容
临床试验/NCT07071298
NCT07071298招募中不适用

A Real World, Observational Pediatric Registry of the Acclarent AERA® Eustachian Tube Balloon Dilation System

Integra LifeSciences Corporation13 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2025年6月17日最近更新:

试验速览

阶段
不适用
状态
招募中
入组人数
300
试验地点
13
主要终点
Failure-free after ETBD with the AERA® device.

研究概览

简要总结

Prospective, multi-center, observational, real-world evidence data collection registry to confirm the continued clinical performance of the AERA® device in pediatric patients

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
— 至 18 Years(Child, Adult)
性别
All
接受健康志愿者

入选标准

  • Specific indications for ETBD are documented
  • ETBD with AERA device attempted-

排除标准

  • ETBD with device other than AERA®
  • Previous ETBD procedure-

结局指标

主要结局

Failure-free after ETBD with the AERA® device.

时间窗: 27 months

Failure is defined as revision ETD surgery (e.g. further ETBD, tympanostomy tube (TT) insertion, or adenoidectomy for ETD).

次要结局

  • Tympanogram assessed by ear(27 months)
  • Pure tone audiometry (PTA) assessed by ear(27 months)
  • Valsalva maneuver assessed by ear(27 months)
  • Inflammation score assessed by ear(27 months)
  • Eustachian Tube Dysfunction Questionnaire (ETDQ-7) assessed by patient(27 months)
  • Otitis Media- 6 Questionnaire (OM-6) assessed by patient(27 months)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (13)

Loading locations...

相似试验

招募中
不适用
Registry for neonates, infants, children, adolescents,and adults with newly diagnosed and/or relapsedneuroblastic tumors(NB Registry 2016)C74.1Medulla of adrenal gland
DRKS00023442K Köln5,000
招募中
不适用
Registry of hospitalized pediatric Patients mit SARS-CoV-2 infection (COVID-19)U07.1COVID-19, virus identified
DRKS00021506niversitätsklinikum Carl Gustav Carus1,000
招募中
不适用
Metastatic ColoRectal cancer India Registry
CTRI/2022/07/043968Dr Reddys Laboratories
招募中
不适用
Register study for the survey of births in patients with deep endometriosisN80Endometriosis
DRKS00016768Kepler Universitätsklinikum500
暂停
不适用
Registry for children, adolescents and adults with Osteosarcoma and biologically related bone sarcomas (COSS-Registry)Malignant high-grade osteosarcoma subtypes (conventional: osteoblastic, chondroblastic, fibroblastic, giant cell rich, osteoblastom-like, epithelioid, clear cell, chondroblastom-likenon-conventional: telangiectatic, small cell, high-grade surface), periosteal, parosteal, extra-skeletal, low-grade central, undifferentiated pleomorphic sarcoma, osseous leiomysarcoma, osseous dedifferentiated chondrosarcoma, osseous mesenchymal chondrosarcoma, osseous fibrosarcoma, osseous angiosarcoma
DRKS00027990Klinikum der Landeshauptstadt Stuttgart gKAöRZentrum für Kinder-, Jugend- und Frauenmedizin Standort Mitte (Olgahospital) Pädiatrie 5 (Onkologie, Hämatologie, Immunologie)Cooperative Osteosarkom Studiengruppe (COSS)1,000